Bristol-Myers Squibb CompanyBMYNYSE
LOADING
|||
BMYNet Debt Over Time
Trending higher, above historical average, strong compound growth.
Left:
|||
Total debt minus cash and cash equivalents
Latest
$40.85B
↑ 89% above average
Average (9y)
$21.61B
Historical baseline
Range
High:$40.85B
Low:$438.00M
CAGR
+28.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $40.85B | +36.2% |
| 2023 | $30.00B | -5.0% |
| 2022 | $31.59B | -0.1% |
| 2021 | $31.62B | -14.8% |
| 2020 | $37.13B | +5.5% |
| 2019 | $35.19B | +7934.7% |
| 2018 | $438.00M | -82.8% |
| 2017 | $2.54B | +2.8% |
| 2016 | $2.47B | -42.6% |
| 2015 | $4.30B | - |